AdaptHealth Corp. (NASDAQ: AHCO) Stock Competitors & Peer Comparison
See AHCO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AHCO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AHCO | $7.33 | -1.08% | 998.7M | 14.95 | $0.49 | N/A |
| ABT | $109.93 | -3.23% | 190.3B | 21.10 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $101.80 | -2.90% | 130.2B | 18.41 | $5.53 | +2.81% |
| SYK | $325.87 | -2.75% | 124.1B | 24.34 | $13.39 | +1.09% |
| BSX | $42.75 | -4.23% | 62B | 13.79 | $3.10 | N/A |
| EW | $102.14 | +1.31% | 58.9B | 37.82 | $2.70 | N/A |
| GEHC | $82.38 | -1.64% | 37.2B | 16.81 | $4.90 | +0.18% |
| PHG | $30.35 | -0.52% | 29.7B | 17.34 | $1.75 | +3.27% |
| DXCM | $79.41 | -5.98% | 29.6B | 31.14 | $2.55 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
AHCO vs ABT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ABT has a market cap of 190.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ABT trades at $109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ABT's P/E ratio is 21.10. In terms of profitability, AHCO's ROE is -0.29%, compared to ABT's ROE of +0.09%. Regarding short-term risk, AHCO is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
AHCO vs BSX-PA Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AHCO's ROE is -0.29%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, AHCO is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
AHCO vs MDT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, MDT has a market cap of 130.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while MDT trades at $101.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas MDT's P/E ratio is 18.41. In terms of profitability, AHCO's ROE is -0.29%, compared to MDT's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
AHCO vs SYK Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SYK trades at $325.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SYK's P/E ratio is 24.34. In terms of profitability, AHCO's ROE is -0.29%, compared to SYK's ROE of +0.16%. Regarding short-term risk, AHCO is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
AHCO vs BSX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BSX has a market cap of 62B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BSX trades at $42.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BSX's P/E ratio is 13.79. In terms of profitability, AHCO's ROE is -0.29%, compared to BSX's ROE of +0.14%. Regarding short-term risk, AHCO is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
AHCO vs EW Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, EW has a market cap of 58.9B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while EW trades at $102.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas EW's P/E ratio is 37.82. In terms of profitability, AHCO's ROE is -0.29%, compared to EW's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
AHCO vs GEHC Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, GEHC has a market cap of 37.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while GEHC trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas GEHC's P/E ratio is 16.81. In terms of profitability, AHCO's ROE is -0.29%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, AHCO is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
AHCO vs PHG Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PHG has a market cap of 29.7B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PHG trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PHG's P/E ratio is 17.34. In terms of profitability, AHCO's ROE is -0.29%, compared to PHG's ROE of +0.08%. Regarding short-term risk, AHCO is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PHG's competition here
DexCom, Inc. (NASDAQ: DXCM)
AHCO vs DXCM Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while DXCM trades at $79.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas DXCM's P/E ratio is 31.14. In terms of profitability, AHCO's ROE is -0.29%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, AHCO is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
AHCO vs ZBH Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ZBH has a market cap of 20.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ZBH trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ZBH's P/E ratio is 12.45. In terms of profitability, AHCO's ROE is -0.29%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, AHCO is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
AHCO vs ABMD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AHCO's ROE is -0.29%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
AHCO vs GKOS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, GKOS has a market cap of 13.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while GKOS trades at $224.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas GKOS's P/E ratio is -260.83. In terms of profitability, AHCO's ROE is -0.29%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, AHCO is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GKOS's competition here
Smith & Nephew plc (NYSE: SNN)
AHCO vs SNN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SNN has a market cap of 13.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SNN trades at $31.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SNN's P/E ratio is 21.03. In terms of profitability, AHCO's ROE is -0.29%, compared to SNN's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
AHCO vs PEN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PEN trades at $319.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PEN's P/E ratio is 83.37. In terms of profitability, AHCO's ROE is -0.29%, compared to PEN's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
AHCO vs SWAV Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AHCO's ROE is -0.29%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, AHCO is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
AHCO vs ALGN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ALGN has a market cap of 11.8B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ALGN trades at $166.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ALGN's P/E ratio is 15.14. In terms of profitability, AHCO's ROE is -0.29%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, AHCO is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
AHCO vs BIO Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BIO trades at $381.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BIO's P/E ratio is 41.12. In terms of profitability, AHCO's ROE is -0.29%, compared to BIO's ROE of +0.14%. Regarding short-term risk, AHCO is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
AHCO vs PODD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PODD trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PODD's P/E ratio is 24.96. In terms of profitability, AHCO's ROE is -0.29%, compared to PODD's ROE of +0.29%. Regarding short-term risk, AHCO is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
AHCO vs BIO-B Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BIO-B has a market cap of 9.9B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BIO-B trades at $374.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BIO-B's P/E ratio is -65.97. In terms of profitability, AHCO's ROE is -0.29%, compared to BIO-B's ROE of +0.14%. Regarding short-term risk, AHCO is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
AHCO vs GMED Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, GMED has a market cap of 9.5B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while GMED trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas GMED's P/E ratio is 16.00. In terms of profitability, AHCO's ROE is -0.29%, compared to GMED's ROE of +0.12%. Regarding short-term risk, AHCO is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
AHCO vs MASI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas MASI's P/E ratio is 44.43. In terms of profitability, AHCO's ROE is -0.29%, compared to MASI's ROE of +0.09%. Regarding short-term risk, AHCO is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
AHCO vs BRKR Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BRKR trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BRKR's P/E ratio is 30.81. In terms of profitability, AHCO's ROE is -0.29%, compared to BRKR's ROE of -0.05%. Regarding short-term risk, AHCO is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
AHCO vs BRKRP Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BRKRP has a market cap of 9.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BRKRP trades at $446.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BRKRP's P/E ratio is 244.34. In terms of profitability, AHCO's ROE is -0.29%, compared to BRKRP's ROE of -0.05%. Regarding short-term risk, AHCO is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
AHCO vs HAE Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, HAE has a market cap of 5.5B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while HAE trades at $119.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas HAE's P/E ratio is 23.93. In terms of profitability, AHCO's ROE is -0.29%, compared to HAE's ROE of +0.12%. Regarding short-term risk, AHCO is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
AHCO vs LIVN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, LIVN has a market cap of 4.9B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while LIVN trades at $89.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas LIVN's P/E ratio is 21.37. In terms of profitability, AHCO's ROE is -0.29%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check LIVN's competition here
Inari Medical, Inc. (NASDAQ: NARI)
AHCO vs NARI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas NARI's P/E ratio is -59.24. In terms of profitability, AHCO's ROE is -0.29%, compared to NARI's ROE of -0.00%. Regarding short-term risk, AHCO is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
AHCO vs ITGR Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ITGR trades at $126.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ITGR's P/E ratio is 19.94. In terms of profitability, AHCO's ROE is -0.29%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, AHCO is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ITGR's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
AHCO vs TMDX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while TMDX trades at $88.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas TMDX's P/E ratio is 44.77. In terms of profitability, AHCO's ROE is -0.29%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, AHCO is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
AHCO vs AXGN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, AXGN has a market cap of 3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while AXGN trades at $50.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas AXGN's P/E ratio is 131.53. In terms of profitability, AHCO's ROE is -0.29%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, AHCO is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AXGN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
AHCO vs IRTC Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, IRTC has a market cap of 3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while IRTC trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas IRTC's P/E ratio is -209.53. In terms of profitability, AHCO's ROE is -0.29%, compared to IRTC's ROE of -0.23%. Regarding short-term risk, AHCO is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
AHCO vs NEOG Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while NEOG trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas NEOG's P/E ratio is 42.00. In terms of profitability, AHCO's ROE is -0.29%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, AHCO is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
AHCO vs UFPT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while UFPT trades at $303.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas UFPT's P/E ratio is 30.94. In terms of profitability, AHCO's ROE is -0.29%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, AHCO is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
AHCO vs NUVA Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AHCO's ROE is -0.29%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AHCO is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
AHCO vs ESTA Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ESTA trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ESTA's P/E ratio is -53.24. In terms of profitability, AHCO's ROE is -0.29%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, AHCO is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
AHCO vs INSP Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while INSP trades at $63.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas INSP's P/E ratio is 28.18. In terms of profitability, AHCO's ROE is -0.29%, compared to INSP's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
AHCO vs BFLY Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BFLY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BFLY's P/E ratio is -26.52. In terms of profitability, AHCO's ROE is -0.29%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, AHCO is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
AHCO vs ENOV Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ENOV trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ENOV's P/E ratio is 7.77. In terms of profitability, AHCO's ROE is -0.29%, compared to ENOV's ROE of -0.36%. Regarding short-term risk, AHCO is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ENOV's competition here
Novocure Ltd (NASDAQ: NVCR)
AHCO vs NVCR Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, NVCR has a market cap of 1.6B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while NVCR trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas NVCR's P/E ratio is -12.52. In terms of profitability, AHCO's ROE is -0.29%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, AHCO is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NVCR's competition here
CONMED Corporation (NYSE: CNMD)
AHCO vs CNMD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CNMD trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CNMD's P/E ratio is 11.32. In terms of profitability, AHCO's ROE is -0.29%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, AHCO is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
AHCO vs HSKA Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AHCO's ROE is -0.29%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AHCO is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check HSKA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
AHCO vs LMRI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, LMRI has a market cap of 1.3B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while LMRI trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas LMRI's P/E ratio is -26.07. In terms of profitability, AHCO's ROE is -0.29%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, AHCO is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check LMRI's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
AHCO vs TNDM Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while TNDM trades at $16.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas TNDM's P/E ratio is -18.18. In terms of profitability, AHCO's ROE is -0.29%, compared to TNDM's ROE of -0.36%. Regarding short-term risk, AHCO is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TNDM's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
AHCO vs PRCT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PRCT trades at $20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PRCT's P/E ratio is -10.62. In terms of profitability, AHCO's ROE is -0.29%, compared to PRCT's ROE of -0.33%. Regarding short-term risk, AHCO is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
AHCO vs AVNS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas AVNS's P/E ratio is 27.77. In terms of profitability, AHCO's ROE is -0.29%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, AHCO is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AVNS's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
AHCO vs ATEC Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ATEC has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ATEC trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ATEC's P/E ratio is -13.21. In terms of profitability, AHCO's ROE is -0.29%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, AHCO is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ATEC's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
AHCO vs SILK Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SILK's P/E ratio is -18.96. In terms of profitability, AHCO's ROE is -0.29%, compared to SILK's ROE of -0.35%. Regarding short-term risk, AHCO is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
AHCO vs FNA Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas FNA's P/E ratio is -19.83. In terms of profitability, AHCO's ROE is -0.29%, compared to FNA's ROE of -0.35%. Regarding short-term risk, AHCO is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
AHCO vs IRMD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while IRMD trades at $86.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas IRMD's P/E ratio is 43.16. In terms of profitability, AHCO's ROE is -0.29%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, AHCO is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check IRMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
AHCO vs SIBN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SIBN has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SIBN trades at $24.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SIBN's P/E ratio is -71.29. In terms of profitability, AHCO's ROE is -0.29%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, AHCO is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SIBN's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
AHCO vs IART Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, IART has a market cap of 1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while IART trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas IART's P/E ratio is 5.69. In terms of profitability, AHCO's ROE is -0.29%, compared to IART's ROE of +0.01%. Regarding short-term risk, AHCO is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check IART's competition here
CeriBell, Inc. (NASDAQ: CBLL)
AHCO vs CBLL Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CBLL trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CBLL's P/E ratio is -15.12. In terms of profitability, AHCO's ROE is -0.29%, compared to CBLL's ROE of -0.55%. Regarding short-term risk, AHCO is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CBLL's competition here
Artivion, Inc. (NYSE: AORT)
AHCO vs AORT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, AORT has a market cap of 985.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while AORT trades at $20.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas AORT's P/E ratio is 33.67. In terms of profitability, AHCO's ROE is -0.29%, compared to AORT's ROE of -0.04%. Regarding short-term risk, AHCO is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AORT's competition here
Picard Medical, Inc. (AMEX: PMI)
AHCO vs PMI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PMI has a market cap of 877.7M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PMI trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PMI's P/E ratio is -7.12. In terms of profitability, AHCO's ROE is -0.29%, compared to PMI's ROE of -9.31%. Regarding short-term risk, AHCO is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
AHCO vs CSII Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CSII's P/E ratio is -20.83. In terms of profitability, AHCO's ROE is -0.29%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AHCO is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
AHCO vs KIDS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, KIDS has a market cap of 829.5M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while KIDS trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas KIDS's P/E ratio is -23.71. In terms of profitability, AHCO's ROE is -0.29%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check KIDS's competition here
Varex Imaging Corporation (NASDAQ: VREX)
AHCO vs VREX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, VREX has a market cap of 783.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while VREX trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas VREX's P/E ratio is 19.42. In terms of profitability, AHCO's ROE is -0.29%, compared to VREX's ROE of +0.05%. Regarding short-term risk, AHCO is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
AHCO vs INMD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, INMD has a market cap of 767.6M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while INMD trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas INMD's P/E ratio is 9.26. In terms of profitability, AHCO's ROE is -0.29%, compared to INMD's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check INMD's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
AHCO vs CTKB Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CTKB has a market cap of 760.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CTKB trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CTKB's P/E ratio is -30.99. In terms of profitability, AHCO's ROE is -0.29%, compared to CTKB's ROE of -0.25%. Regarding short-term risk, AHCO is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CTKB's competition here
Bioventus Inc. (NASDAQ: BVS)
AHCO vs BVS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BVS has a market cap of 725.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BVS trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BVS's P/E ratio is 13.93. In terms of profitability, AHCO's ROE is -0.29%, compared to BVS's ROE of +0.27%. Regarding short-term risk, AHCO is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BVS's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
AHCO vs BBNX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BBNX has a market cap of 706.8M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BBNX trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BBNX's P/E ratio is -8.54. In terms of profitability, AHCO's ROE is -0.29%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, AHCO is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BBNX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
AHCO vs PACB Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PACB has a market cap of 700.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PACB trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PACB's P/E ratio is -5.50. In terms of profitability, AHCO's ROE is -0.29%, compared to PACB's ROE of +6.04%. Regarding short-term risk, AHCO is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PACB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
AHCO vs SRDX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SRDX's P/E ratio is -34.66. In terms of profitability, AHCO's ROE is -0.29%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SRDX's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
AHCO vs TCMD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, TCMD has a market cap of 583.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while TCMD trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas TCMD's P/E ratio is 24.10. In terms of profitability, AHCO's ROE is -0.29%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check TCMD's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
AHCO vs APEN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas APEN's P/E ratio is -9.43. In terms of profitability, AHCO's ROE is -0.29%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AHCO is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check APEN's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
AHCO vs SGHT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SGHT has a market cap of 556.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SGHT trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SGHT's P/E ratio is -18.04. In terms of profitability, AHCO's ROE is -0.29%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, AHCO is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check SGHT's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
AHCO vs AVR Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, AVR has a market cap of 554.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while AVR trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas AVR's P/E ratio is -2.93. In terms of profitability, AHCO's ROE is -0.29%, compared to AVR's ROE of -0.78%. Regarding short-term risk, AHCO is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AVR's competition here
ZimVie Inc. (NASDAQ: ZIMV)
AHCO vs ZIMV Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, AHCO's ROE is -0.29%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, AHCO is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ZIMV's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
AHCO vs DCTH Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, DCTH has a market cap of 518.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while DCTH trades at $14.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas DCTH's P/E ratio is 1494.00. In terms of profitability, AHCO's ROE is -0.29%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, AHCO is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check DCTH's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
AHCO vs SENS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SENS has a market cap of 453.7M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SENS trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SENS's P/E ratio is -3.85. In terms of profitability, AHCO's ROE is -0.29%, compared to SENS's ROE of -1.66%. Regarding short-term risk, AHCO is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check SENS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
AHCO vs SSII Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SSII has a market cap of 430M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SSII trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SSII's P/E ratio is -35.75. In terms of profitability, AHCO's ROE is -0.29%, compared to SSII's ROE of -0.27%. Regarding short-term risk, AHCO is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check SSII's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
AHCO vs NPCE Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, NPCE has a market cap of 428.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while NPCE trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas NPCE's P/E ratio is -21.89. In terms of profitability, AHCO's ROE is -0.29%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, AHCO is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
AHCO vs RCEL Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, RCEL has a market cap of 412.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while RCEL trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas RCEL's P/E ratio is -11.53. In terms of profitability, AHCO's ROE is -0.29%, compared to RCEL's ROE of +1.46%. Regarding short-term risk, AHCO is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check RCEL's competition here
Cerus Corporation (NASDAQ: CERS)
AHCO vs CERS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CERS has a market cap of 406.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CERS trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CERS's P/E ratio is -66.94. In terms of profitability, AHCO's ROE is -0.29%, compared to CERS's ROE of -0.11%. Regarding short-term risk, AHCO is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CERS's competition here
CapsoVision, Inc. (NASDAQ: CV)
AHCO vs CV Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CV has a market cap of 336M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CV trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CV's P/E ratio is -10.02. In terms of profitability, AHCO's ROE is -0.29%, compared to CV's ROE of -1.78%. Regarding short-term risk, AHCO is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CV's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
AHCO vs OFIX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, OFIX has a market cap of 317.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while OFIX trades at $7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas OFIX's P/E ratio is -5.12. In terms of profitability, AHCO's ROE is -0.29%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, AHCO is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
AHCO vs SMLR Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas SMLR's P/E ratio is 3.92. In terms of profitability, AHCO's ROE is -0.29%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, AHCO is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
AHCO vs CLPT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CLPT has a market cap of 275.5M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CLPT trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CLPT's P/E ratio is -7.28. In terms of profitability, AHCO's ROE is -0.29%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, AHCO is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
AHCO vs INFU Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, INFU has a market cap of 273.5M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while INFU trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas INFU's P/E ratio is 33.49. In terms of profitability, AHCO's ROE is -0.29%, compared to INFU's ROE of +0.16%. Regarding short-term risk, AHCO is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check INFU's competition here
Profound Medical Corp. (NASDAQ: PROF)
AHCO vs PROF Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, PROF has a market cap of 263.8M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while PROF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas PROF's P/E ratio is -7.37. In terms of profitability, AHCO's ROE is -0.29%, compared to PROF's ROE of -0.28%. Regarding short-term risk, AHCO is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PROF's competition here
Quantum-Si incorporated (NASDAQ: QSI)
AHCO vs QSI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, QSI has a market cap of 263.6M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while QSI trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas QSI's P/E ratio is -2.88. In terms of profitability, AHCO's ROE is -0.29%, compared to QSI's ROE of -0.45%. Regarding short-term risk, AHCO is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
AHCO vs TMCI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, TMCI has a market cap of 262.7M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while TMCI trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas TMCI's P/E ratio is -4.30. In terms of profitability, AHCO's ROE is -0.29%, compared to TMCI's ROE of -0.76%. Regarding short-term risk, AHCO is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
AHCO vs MGRM Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas MGRM's P/E ratio is -12.00. In terms of profitability, AHCO's ROE is -0.29%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, AHCO is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
AHCO vs NVRO Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AHCO's ROE is -0.29%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AHCO is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
AHCO vs ELMD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ELMD has a market cap of 223.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ELMD trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ELMD's P/E ratio is 20.58. In terms of profitability, AHCO's ROE is -0.29%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, AHCO is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
AHCO vs TLSI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, TLSI has a market cap of 199.5M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while TLSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas TLSI's P/E ratio is -1.93. In terms of profitability, AHCO's ROE is -0.29%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, AHCO is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TLSI's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
AHCO vs BSGM Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas BSGM's P/E ratio is -5.81. In terms of profitability, AHCO's ROE is -0.29%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, AHCO is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BSGM's competition here
RxSight, Inc. (NASDAQ: RXST)
AHCO vs RXST Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, RXST has a market cap of 188.6M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while RXST trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas RXST's P/E ratio is -4.01. In terms of profitability, AHCO's ROE is -0.29%, compared to RXST's ROE of -0.20%. Regarding short-term risk, AHCO is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
AHCO vs MDGS Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas MDGS's P/E ratio is -0.27. In terms of profitability, AHCO's ROE is -0.29%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, AHCO is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
AHCO vs STIM Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, STIM has a market cap of 163.4M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while STIM trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas STIM's P/E ratio is -4.87. In terms of profitability, AHCO's ROE is -0.29%, compared to STIM's ROE of -1.28%. Regarding short-term risk, AHCO is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
AHCO vs QIPT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas QIPT's P/E ratio is -15.87. In terms of profitability, AHCO's ROE is -0.29%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, AHCO is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
AHCO vs INGN Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, INGN has a market cap of 160M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while INGN trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas INGN's P/E ratio is -6.63. In terms of profitability, AHCO's ROE is -0.29%, compared to INGN's ROE of -0.20%. Regarding short-term risk, AHCO is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
AHCO vs QTRX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, QTRX has a market cap of 137.1M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while QTRX trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas QTRX's P/E ratio is -1.14. In terms of profitability, AHCO's ROE is -0.29%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, AHCO is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
AHCO vs FOCL Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, FOCL has a market cap of 125.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while FOCL trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas FOCL's P/E ratio is -3.25. In terms of profitability, AHCO's ROE is -0.29%, compared to FOCL's ROE of -2.41%. Regarding short-term risk, AHCO is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check FOCL's competition here
Owlet, Inc. (NYSE: OWLT)
AHCO vs OWLT Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, OWLT has a market cap of 121.6M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while OWLT trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas OWLT's P/E ratio is -29.71. In terms of profitability, AHCO's ROE is -0.29%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, AHCO is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check OWLT's competition here
Pulmonx Corporation (NASDAQ: LUNG)
AHCO vs LUNG Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, LUNG has a market cap of 109.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while LUNG trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas LUNG's P/E ratio is -2.53. In terms of profitability, AHCO's ROE is -0.29%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, AHCO is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check LUNG's competition here
iCAD, Inc. (NASDAQ: ICAD)
AHCO vs ICAD Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ICAD's P/E ratio is -20.37. In terms of profitability, AHCO's ROE is -0.29%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, AHCO is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
AHCO vs HJLI Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas HJLI's P/E ratio is N/A. In terms of profitability, AHCO's ROE is -0.29%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, AHCO is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check HJLI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
AHCO vs CATX Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, CATX has a market cap of 95.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while CATX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas CATX's P/E ratio is -0.63. In terms of profitability, AHCO's ROE is -0.29%, compared to CATX's ROE of -0.42%. Regarding short-term risk, AHCO is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CATX's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
AHCO vs ASXC Comparison November 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 998.7M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, AHCO is priced at $7.33 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 14.95, whereas ASXC's P/E ratio is -1.12. In terms of profitability, AHCO's ROE is -0.29%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, AHCO is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ASXC's competition here